Publications
Detailed Information
Hemin inhibits cyclin D1 and IGF-1 expression via STAT5b under hypoxia in ER alpha-negative MDA-MB 231 breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Eun-Joung | - |
dc.contributor.author | Joung, Youn-Hee | - |
dc.contributor.author | Jung, Se-Mi | - |
dc.contributor.author | Park, Se Hyung | - |
dc.contributor.author | Kim, Sang Yoon | - |
dc.contributor.author | Hong, Dae Young | - |
dc.contributor.author | Ye, Sang-Kyu | - |
dc.contributor.author | Park, Eui U. | - |
dc.contributor.author | Chung, Ill-Min | - |
dc.contributor.author | Yang, Young Mok | - |
dc.contributor.author | Park, Taekyu | - |
dc.contributor.author | Moon, Eon-Soo | - |
dc.contributor.author | Chung, So Chung | - |
dc.contributor.author | Hwang, Tae Sook | - |
dc.contributor.author | Park, Jin Hee | - |
dc.date.accessioned | 2012-07-02T04:49:16Z | - |
dc.date.available | 2012-07-02T04:49:16Z | - |
dc.date.issued | 2010-05 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF ONCOLOGY; Vol.36 5; 1243-1251 | ko_KR |
dc.identifier.issn | 1019-6439 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78072 | - |
dc.description.abstract | Cychn D1 and insulin-like growth factor 1 receptor (IGE-IR) are key regulators of cell proliferation that are overexpressed in most breast cancers The purpose of the present study was to investigate the molecular mechanism by which hemin exerts its inhibitory effects on aggressive breast cancer cells We found that hemin regulates cychn DI and ICE-I R proteins and insulin-like growth factor-1 gene expression through STAT5b in breast cancer cells. We confirmed that STAT5b. cyclin DI. and IGE-1R is up-regulated by hypoxia. and the increased sTAT5b binds strongly to the STAT5-binding sites contained within the distal 5-flanking region of IGE-1 acne in breast cancer cells EMSA studies showed that S1`AT5 binding activity to the IGE-1 and cychn DI promoter was distinctly decreased by hemin in STAT5b-transfected COS-7 or MDA-MB 231 cells. IGE-1 gene expression was also decreased by hemin in mammary epithelial cells STAT5b expression was inhibited in sr RNA experiments and by hermit. leadma to decreased levels of IGE-1 These results provide a basis for molecular targets in cancer treatment via the STAT5b/IGE-1 or /cychn DI pathway in solid tumor cells These data indicate that hem in inhibits the cyclin D1 and IGE-1 expression via STAT5b under hypoxia in ER alpha-negative breast cancer cells These findings are valuable toward understanding the role of hemin-induced inhibition of cyclin D1 and IGF-1 expression under hypoxia in Invasive and metastatic breast cancer | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | SPANDIDOS PUBL LTD | ko_KR |
dc.subject | hemin | ko_KR |
dc.subject | cyclin D1 | ko_KR |
dc.subject | MDA-MB 231 | ko_KR |
dc.subject | binding site | ko_KR |
dc.subject | gene expression | ko_KR |
dc.subject | breast cancer cells | ko_KR |
dc.subject | IGF-IR | ko_KR |
dc.subject | hypoxia | ko_KR |
dc.subject | STAT5b | ko_KR |
dc.subject | IGF-1 | ko_KR |
dc.title | Hemin inhibits cyclin D1 and IGF-1 expression via STAT5b under hypoxia in ER alpha-negative MDA-MB 231 breast cancer cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 임은정 | - |
dc.contributor.AlternativeAuthor | 정윤희 | - |
dc.contributor.AlternativeAuthor | 정세미 | - |
dc.contributor.AlternativeAuthor | 박세형 | - |
dc.contributor.AlternativeAuthor | 박진희 | - |
dc.contributor.AlternativeAuthor | 김상윤 | - |
dc.contributor.AlternativeAuthor | 황태숙 | - |
dc.contributor.AlternativeAuthor | 홍대영 | - |
dc.contributor.AlternativeAuthor | 정소정 | - |
dc.contributor.AlternativeAuthor | 예상규 | - |
dc.contributor.AlternativeAuthor | 문언수 | - |
dc.contributor.AlternativeAuthor | 박의유 | - |
dc.contributor.AlternativeAuthor | 박태규 | - |
dc.contributor.AlternativeAuthor | 정일민 | - |
dc.contributor.AlternativeAuthor | 양영목 | - |
dc.identifier.doi | 10.3892/ijo_00000608 | - |
dc.citation.journaltitle | INTERNATIONAL JOURNAL OF ONCOLOGY | - |
dc.description.citedreference | Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341 | - |
dc.description.citedreference | Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030 | - |
dc.description.citedreference | Diorio C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2093 | - |
dc.description.citedreference | Tian XB, 2007, J NUCL MED, V48, P1699, DOI 10.2967/jnumed.107.042499 | - |
dc.description.citedreference | Tworoger SS, 2007, CANCER CAUSE CONTROL, V18, P743, DOI 10.1007/s10552-007-9017-5 | - |
dc.description.citedreference | Cui Y, 2007, CANCER EPIDEM BIOMAR, V16, P1682, DOI 10.1158/1055-9965.EPI-07-0187 | - |
dc.description.citedreference | Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201 | - |
dc.description.citedreference | Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794 | - |
dc.description.citedreference | Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017 | - |
dc.description.citedreference | Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519 | - |
dc.description.citedreference | Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871 | - |
dc.description.citedreference | Lee MY, 2006, BREAST, V15, P187, DOI 10.1016/j.breast.2005.05.005 | - |
dc.description.citedreference | Hwang PH, 2005, EXP MOL MED, V37, P391 | - |
dc.description.citedreference | Joung YH, 2005, EXP MOL MED, V37, P353 | - |
dc.description.citedreference | Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200 | - |
dc.description.citedreference | Lang D, 2005, INT IMMUNOL, V17, P155, DOI 10.1093/intimm/dxh196 | - |
dc.description.citedreference | Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031 | - |
dc.description.citedreference | GABEI K, 2005, J NATL CANCER I, V97, P790 | - |
dc.description.citedreference | Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008 | - |
dc.description.citedreference | Ibrahim YH, 2004, GROWTH HORM IGF RES, V14, P261, DOI 10.1016/j.ghir.2004.01.005 | - |
dc.description.citedreference | Gonzalez-Michaca L, 2004, AM J PHYSIOL-RENAL, V286, pF370, DOI 10.1152/ajprenal.00300.2003 | - |
dc.description.citedreference | Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200 | - |
dc.description.citedreference | Joung YH, 2003, EXP MOL MED, V35, P350 | - |
dc.description.citedreference | Bando H, 2003, BIOMED PHARMACOTHER, V57, P333, DOI 10.1016/S0753-3322(03)00098-2 | - |
dc.description.citedreference | Nakahira K, 2003, BIOCHEM PHARMACOL, V66, P1091, DOI 10.1016/S0006-2952(03)00444-1 | - |
dc.description.citedreference | Richardson DR, 2003, J LAB CLIN MED, V141, P289, DOI 10.1016/S0022-2143(03)00003-9 | - |
dc.description.citedreference | Amon M, 2003, FASEB J, V17, P175 | - |
dc.description.citedreference | Wilson SJ, 2003, VASC PHARMACOL, V40, P109, DOI 10.1016/S1537-1891(02)00340-3 | - |
dc.description.citedreference | Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619 | - |
dc.description.citedreference | Martin MB, 2002, J NUTR, V132, p3799S | - |
dc.description.citedreference | Duan C, 2002, J ENDOCRINOL, V175, P41 | - |
dc.description.citedreference | Schaaf GJ, 2002, FREE RADICAL RES, V36, P835, DOI 10.1080/1071576021000005267 | - |
dc.description.citedreference | Suliman HB, 2002, FREE RADICAL BIO MED, V32, P246 | - |
dc.description.citedreference | OSHEA JJ, 2002, CELL S1, V109, P21 | - |
dc.description.citedreference | Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151 | - |
dc.description.citedreference | Davey HW, 2001, ENDOCRINOLOGY, V142, P3836 | - |
dc.description.citedreference | Yu QY, 2001, NATURE, V411, P1017 | - |
dc.description.citedreference | Bienvenu F, 2001, J BIOL CHEM, V276, P16840 | - |
dc.description.citedreference | Park JH, 2000, J BIOCHEM MOL BIOL, V33, P396 | - |
dc.description.citedreference | Ariyoshi K, 2000, J BIOL CHEM, V275, P24407 | - |
dc.description.citedreference | Clark JE, 2000, BIOCHEM J, V348, P615 | - |
dc.description.citedreference | Bowman T, 2000, ONCOGENE, V19, P2474 | - |
dc.description.citedreference | Yamada N, 1999, AM J RESP CELL MOL, V21, P428 | - |
dc.description.citedreference | Kazansky AV, 1999, J BIOL CHEM, V274, P22484 | - |
dc.description.citedreference | Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131 | - |
dc.description.citedreference | Matsumura I, 1999, EMBO J, V18, P1367 | - |
dc.description.citedreference | Teglund S, 1998, CELL, V93, P841 | - |
dc.description.citedreference | Rund D, 1998, ACTA HAEMATOL-BASEL, V100, P82 | - |
dc.description.citedreference | Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239 | - |
dc.description.citedreference | Liu XW, 1997, GENE DEV, V11, P179 | - |
dc.description.citedreference | Onishi M, 1996, EXP HEMATOL, V24, P324 | - |
dc.description.citedreference | JONES JI, 1995, ENDOCR REV, V16, P3 | - |
dc.description.citedreference | BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285 | - |
dc.description.citedreference | BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899 | - |
dc.description.citedreference | MACAULAY VM, 1992, BRIT J CANCER, V65, P311 | - |
dc.description.citedreference | DAUGHADAY WH, 1989, ENDOCR REV, V10, P68 | - |
dc.description.citedreference | GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861 | - |
dc.description.citedreference | AFT RL, 1984, J BIOL CHEM, V259, P301 | - |
dc.description.citedreference | BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509 | - |
dc.description.citedreference | RUTHERFORD TR, 1979, NATURE, V280, P164 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.